about
ZAP-70 restoration in mice by in vivo thymic electroporationAntigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.Engineering New Approaches to Cancer VaccinesTargeting the extracellular membrane-proximal domain of membrane-bound IgE by passive immunization blocks IgE synthesis in vivo.Principles of tumor immunosurveillance and implications for immunotherapy.Intralymphatic immunotherapyTranscription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine.In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particlesIntralymphatic immunotherapy and vaccination in mice.Approaches to enhance the efficacy of DNA vaccines.Attenuated salmonella and Shigella as carriers for DNA vaccines.DNA vaccines suppress tumor growth and metastases by the induction of anti-angiogenesis.Intralymphatic treatment of flagellin-ovalbumin mixture reduced allergic inflammation in murine model of allergic rhinitis.A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responsesRecombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate.Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens.Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.New routes for allergen immunotherapy.Induction of T helper 1 response by immunization of BALB/c mice with the gene encoding the second subunit of Echinococcus granulosus antigen B (EgAgB8/2).Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial.A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors.Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cellsIntradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice.Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administrationLymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors.mRNA vaccination as a safe approach for specific protection from type I allergy.Novel routes for allergen immunotherapy: safety, efficacy and mode of action.mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.The ReNAissanCe of mRNA-based cancer therapy.The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases.Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy.Allergen immunotherapy: routes, safety, efficacy, and mode of action.Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents.Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.Systemic administration of naked DNA with targeting specificity to mammalian kidneys.Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?Programmed cell death-1 (PD-1) at the heart of heterologous prime-boost vaccines and regulation of CD8+ T cell immunity.Direct intralymphatic injection of peptide vaccines enhances immunogenicity.Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges.T-Cell Dysfunction in Glioblastoma: Applying a New Framework.
P2860
Q21092215-A9AB96F8-7B88-49B6-A4A7-0959503A787CQ27687250-52B14290-09C2-46DD-A2E0-DB234CB10A38Q28085563-7C19BBC9-1A3A-4EC7-A48D-763A4D2CB71CQ34222417-B9975577-4790-4F46-A66A-3FE175BC30ADQ35043113-DAF18F65-61DC-4EF8-8D71-186BD88113FDQ35155423-4F7DBB26-EFC5-476D-A504-C6B9F8192204Q35170949-CC6B9DDB-46DF-4E06-8822-9776A92931B8Q35229225-D5794D38-946B-4964-9EA7-88E94347669FQ35389863-64DB822D-E086-427F-9D4C-95D550CC5908Q35743279-11DB0C7C-D64B-4EE9-BD3C-681EE9C38CCCQ35809245-E09D57D0-B475-41FE-AE84-379A66610B41Q35826396-38D8F619-2688-46FF-A672-55C9040ACD15Q35890390-23313711-952C-4408-8C4B-44258E50DCB6Q35990046-DC493338-B097-4B3B-94F5-EE4E017A79D3Q36141610-53D530E5-4432-428E-B5F5-D8DBEC4CF9C5Q36198661-A2D4EA87-0849-446F-91F9-7F38EB28AC31Q36780146-650A9612-4F5C-46A7-9C3F-ED018040E4F6Q36864957-4F5BF34D-3CBE-4695-A2D0-20FCA78C3638Q36899214-E6D560CB-EC78-46A5-8F2E-242BCBA16762Q36970017-40563479-38CC-4FBB-8A51-7B8D57D54892Q37007590-85724030-3F93-4BF3-8220-F57D85381C9DQ37116700-FBB01418-FC88-4B43-A218-A0BDDC7D194DQ37290106-D9E1E591-DC84-4715-964C-3FB47123C50FQ37360660-16B2F05D-3FA8-4F73-BB56-BCB26C71BAD4Q37374278-D5063EDE-DDDD-476D-84CE-067F47CCC8A0Q37965722-62C7E7B8-1F5B-44A1-A9FC-839B17E3B6CCQ37984572-C40BF169-F02F-49F4-AC5B-0EC623129793Q38071900-08E300DA-B8C0-49C7-B265-2DC8CC4EAF85Q38255012-9E384F11-4901-4469-91ED-EE0E2AF100C6Q38259275-33316142-C4C7-4C5E-B852-CFCC4ADE289AQ38317118-F3DAD79B-8AED-4853-B89E-E2EDEA9F5FE0Q38912244-9689BD36-D043-4110-8420-4104A9198117Q39365796-CAD11437-C8CC-407D-9620-0DA662E3D14EQ40344509-A35BC4D4-3E1E-4B10-8424-A1902734A29CQ40472167-6B58B19F-193C-4295-B7C2-2782F7066914Q41520681-71B2474B-DB90-41BE-980C-6D2DB477952BQ41526077-FF4C285A-F2ED-41AF-93B8-805ADBBFD949Q43596580-1249A0BF-6C51-4667-8069-B59D4D4F295EQ47940254-5285FC0D-3497-4DB4-BDFA-60D4F4A2FFD9Q52625023-C01AEE00-A811-43A5-BE0E-F2BA63212681
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Intralymphatic immunization enhances DNA vaccination.
@ast
Intralymphatic immunization enhances DNA vaccination.
@en
Intralymphatic immunization enhances DNA vaccination.
@nl
type
label
Intralymphatic immunization enhances DNA vaccination.
@ast
Intralymphatic immunization enhances DNA vaccination.
@en
Intralymphatic immunization enhances DNA vaccination.
@nl
prefLabel
Intralymphatic immunization enhances DNA vaccination.
@ast
Intralymphatic immunization enhances DNA vaccination.
@en
Intralymphatic immunization enhances DNA vaccination.
@nl
P2093
P2860
P356
P1476
Intralymphatic immunization enhances DNA vaccination
@en
P2093
Zinkernagel RM
P2860
P304
P356
10.1073/PNAS.051630798
P407
P50
P577
2001-02-27T00:00:00Z